Back
National Australia Bank Vs. Corcept Therapeutics Industry Stock Comparison
Sell
43
NABZY
National Australia Bank
Last Price:
$11.76
Seasonality Move:
0.12%
Buy
64
CORT
Corcept Therapeutics
Last Price:
$70.25
Seasonality Move:
10.06%
Sell
43
National Australia Bank (NABZY)
is a Sell
Is National Australia Bank a Buy, Sell or Hold?
-
The current National Australia Bank [NABZY] share price is $11.76. The Score for NABZY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
NABZY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
-
The current Corcept Therapeutics [CORT] share price is $70.23. The Score for CORT is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
CORT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NABZY Stock Price Chart
What is National Australia Bank's stock price today?
-
The National Australia Bank share price today is $11.76Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NABZY is experiencing slight buying pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $70.23The current trend is moderately bullish and CORT is experiencing slight selling pressure.
NABZY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.27 | Buy |
Relative Strength Index (14 RSI): | 61.06 | Buy |
Chaikin Money Flow: | 6115 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.34 - 11.7) | Buy |
Bollinger Bands (100): | (10.63 - 12.23) | Buy |
CORT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.56 | Buy |
Relative Strength Index (14 RSI): | 50.58 | Buy |
Chaikin Money Flow: | -342727 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (66.65 - 73.37) | Buy |
Bollinger Bands (100): | (52.88 - 72.86) | Buy |
NABZY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.64 | Buy |
20-day SMA: | 11.29 | Buy |
50-day SMA: | 10.83 | Buy |
200-day SMA: | 12.08 | Sell |
8-day EMA: | 11.63 | Buy |
20-day EMA: | 11.34 | Buy |
50-day EMA: | 11.2 | Buy |
200-day EMA: | 11.6 | Buy |
CORT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 71.61 | Sell |
20-day SMA: | 69.49 | Buy |
50-day SMA: | 66.33 | Buy |
200-day SMA: | 53.55 | Buy |
8-day EMA: | 71.08 | Sell |
20-day EMA: | 68.84 | Buy |
50-day EMA: | 53.77 | Buy |
200-day EMA: | 21.22 | Buy |
National Australia Bank Earnings Growth & NABZY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and a decrease next year of $0.01 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.03 per share, and an increase next year of $1.28 per share.
National Australia Bank Technical Analysis
Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corcept Therapeutics Technical Analysis
Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |